Richter BioLogics

Richter BioLogics is a world-class and expanding cGMP contract manufacturer (CDMO) of biopharmaceuticals, specialising in products derived from bacteria and yeast, based in Hamburg, Germany. We are recognised as a strong and experienced partner that offers one-stop solutions, including consultancy services. Over the past 35 years, Richter BioLogics has gained extensive experience in the development and manufacture of various product classes such as proteins, antibody-like scaffolds (VHH, Fab fragments, nanobodies), plasmid DNA (pDNA) using our proprietary pART process and vaccines. The company currently operates one development facility and two cGMP microbial production facilities. Richter BioLogics has now taken the next...

Microbial-derived biopharmaceuticals,strain development,establishment of cell banks,process development,development and validation of analytical methods,including biological assays,supply of products for clinic phase i - iii,commercial gmp manufacturing,in-house qc testing and release ,stability studies according to ich - guidelines,process validation,ppq,vhh/nanobody production,pdna production,rhb-part process,and protein production

Richter biologics operates in the Biotechnology research industry.

Richter biologics's revenue is 11m - 100m

Richter biologics has 51 - 200 employees.